Europe Clinical Trial Supplies Market Size & Outlook
Europe clinical trial supplies market, 2018-2030 (US$M)
Related Markets
Europe clinical trial supplies market highlights
- The Europe clinical trial supplies market generated a revenue of USD 626.8 million in 2023.
- The market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase III is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 626.8 million |
| Market revenue in 2030 | USD 949.7 million |
| Growth rate | 6.1% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase III |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.3% of the global clinical trial supplies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 704.4 million by 2030.
Phase iii was the largest segment with a revenue share of 53.7% in 2023. Horizon Databook has segmented the Europe clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is one of the leading markets for clinical trial supplies owing to advancements in technology, increasing clinical trials in this region, and presence of innovator biopharmaceutical companies & CROs. According to Outsourcing Survey by Nice Insights, in 2016, there was a 3.0% rise in projects outsourced to Western Europe from 11.0% to 14.0%.
This can be attributed to the fact that biopharmaceutical companies prefer conducting research in established markets such as Europe and North America as compared to emerging markets, due to the presence of a well-established healthcare infrastructure.
Emerging economies such as Eastern Europe are expected to exhibit rapid growth in clinical trials outsourcing market owing to faster process and cost-effectiveness. A survey by Pharma IQ and Clinical Supply Europe estimated that logistics and distribution are among the major outsourced functions in clinical trial supplies market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe clinical trial supplies market size, by country, 2018-2030 (US$M)
Europe Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
